Trial of Amrubicin as Treatment for Patients With HER2-Negative Metastatic Breast Cancer
Clinical trial NCT01033032 · COMPLETED
Trial details
- NCT number
- NCT01033032
- Sponsor
- SCRI Development Innovations, LLC
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-12-01
- Primary completion
- 2013-07-01
- Enrollment
- 78
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.